awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36009462-5417EA18-DFEF-4AB6-A6E0-A526F7C70848
Q36009462-5417EA18-DFEF-4AB6-A6E0-A526F7C70848
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36009462-5417EA18-DFEF-4AB6-A6E0-A526F7C70848
Review of the Reporting of Survival Analyses within Randomised Controlled Trials and the Implications for Meta-Analysis.
P2860
Q36009462-5417EA18-DFEF-4AB6-A6E0-A526F7C70848
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36009462-5417EA18-DFEF-4AB6-A6E0-A526F7C70848
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
18a0255de98983c2c4e90d00e210264a1132857c
P2860
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.